Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$204M |
| 2 |
Peloton Interactive
PTON
|
+$199M |
| 3 |
Ecolab
ECL
|
+$185M |
| 4 |
Canadian National Railway
CNI
|
+$176M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$740M |
| 2 |
Microsoft
MSFT
|
+$500M |
| 3 |
Visa
V
|
+$424M |
| 4 |
Texas Instruments
TXN
|
+$369M |
| 5 |
Verizon
VZ
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.48% |
| 2 | Healthcare | 13.27% |
| 3 | Financials | 11.58% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Viemed Healthcare
VMD
$353M
| $615K | ﹤0.01% |
117,835
+3,050
| +3% | +$17K |
|
|
NMTR
3602
DELISTED
9 Meters Biopharma
NMTR
| $613K | ﹤0.01% |
31,360
+782
| +3% | +$17.5K |
|
3603
Aligos Therapeutics
ALGS
$43.7M
| $612K | ﹤0.01% |
2,065
+125
| +6% | +$45.6K |
|
|
APLT
3604
DELISTED
Applied Therapeutics
APLT
| $612K | ﹤0.01% |
68,396
+933
| +1% | +$12.3K |
|
3605
Silvercrest Asset Management
SAMG
$78.6M
| $611K | ﹤0.01% |
35,589
-298
| -0.8% | -$4.83K |
|
3606
Fortress Biotech
FBIO
$91.4M
| $610K | ﹤0.01% |
16,276
+254
| +2% | +$11.3K |
|
3607
Mizuho Financial
MFG
$132B
| $610K | ﹤0.01% |
239,088
-61,723
| -21% | -$163K |
|
3608
Schwab US Large-Cap Growth ETF
SCHG
$63.2B
| $609K | ﹤0.01% |
29,736
-7,696
| -21% | -$154K |
|
3609
Teekay
TK
$1.03B
| $607K | ﹤0.01% |
193,222
+5,524
| +3% | +$19.1K |
|
3610
Bank7 Corp
BSVN
$495M
| $606K | ﹤0.01% |
26,332
+91
| +0.3% | +$2.19K |
|
3611
Goldman Sachs Access Inflation Protected USD Bond ETF
GTIP
$296M
| $606K | ﹤0.01% |
10,360
+843
| +9% | +$49.2K |
|
|
VINC
3612
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $605K | ﹤0.01% |
2,972
+443
| +18% | +$111K |
|
3613
Lincoln Educational Services
LINC
$945M
| $604K | ﹤0.01% |
80,764
-3,392
| -4% | -$24.6K |
|
3614
VanEck Biotech ETF
BBH
$428M
| $602K | ﹤0.01% |
3,181
-94
| -3% | -$18.1K |
|
|
FONR
3615
DELISTED
Fonar
FONR
| $602K | ﹤0.01% |
40,256
+1,419
| +4% | +$22.8K |
|
3616
Pulse Biosciences
PLSE
$3.09B
| $601K | ﹤0.01% |
40,553
+806
| +2% | +$16.1K |
|
3617
Korro Bio
KRRO
$197M
| $600K | ﹤0.01% |
2,339
-18
| -0.8% | -$5.47K |
|
|
PFSW
3618
DELISTED
PFSweb, Inc.
PFSW
| $598K | ﹤0.01% |
46,433
+19,928
| +75% | +$257K |
|
|
INFI
3619
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $597K | ﹤0.01% |
265,409
+4,052
| +2% | +$10.2K |
|
3620
Graham Corp
GHM
$1.33B
| $594K | ﹤0.01% |
47,753
-12,319
| -21% | -$158K |
|
3621
ARK Web x.0 ETF
ARKW
$1.82B
| $592K | ﹤0.01% |
+4,991
| New | +$706K |
|
3622
iShares S&P India Nifty 50 Index Fund
INDY
$562M
| $592K | ﹤0.01% |
12,506
+7,156
| +134% | +$363K |
|
|
USX
3623
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $592K | ﹤0.01% |
100,884
-1,875
| -2% | -$14.1K |
|
|
MN
3624
DELISTED
MANNING & NAPIER, INC.
MN
| $591K | ﹤0.01% |
71,128
+45,852
| +181% | +$399K |
|
3625
CuriosityStream
CURI
$237M
| $589K | ﹤0.01% |
99,421
+18,674
| +23% | +$157K |
|
Similar funds
Bank of New York Mellon's Q4 2021 Portfolio in Review
As of Q4 2021, Bank of New York Mellon held 4,753 positions worth $554B, up 8.2% from $512B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q4 2021 filing shows 234 new, 2,052 increased, 1,966 reduced and 138 closed positions. Its largest new stake was Rivian: 608,811 shares worth $63.1M. The largest sale was Apple, an estimated $740M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2021 buy was Rivian: 608,811 shares worth $63.1M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q4 2021, an estimated $204M increase.
- Bank of New York Mellon's biggest Q4 2021 reduction was Apple, cutting an estimated $740M.
- Bank of New York Mellon fully exited Kansas City Southern in Q4 2021, selling an estimated $195M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $554B portfolio in Q4 2021.
- Bank of New York Mellon opened 234 new positions and closed 138 in Q4 2021.
- Bank of New York Mellon's portfolio value rose 8.2% quarter-over-quarter to $554B.
Based on Bank of New York Mellon's 13F filing for Q4 2021, filed 11 Feb 2022.